sunitinib

Trials studying sunitinib

• phase2Pan Tumor Rollover Studyrecruitingn=1,500
• phase3A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Studyactive not recruitingn=1,000
• —Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumorsavailable
• phase2Pre-Surgical Sutent in Renal Cell Carcinoma (RCC)active not recruitingn=50
• phase3A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapyrecruitingn=450
• phase2TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancerrecruitingn=4,200
• phase2Thyroid Cancer and Sunitinibcompletedn=71
• phase3Savolitinib vs. Sunitinib in MET-driven PRCC.active not recruitingn=60